Revelis BioEclipse SPV LLC, a Series of Revelis SPV Master, LLC — Form D/A
Revelis BioEclipse SPV LLC, a Series of Revelis SPV Master, LLC of Denver, CO, a pooled investment fund, filed a Form D amendment with the SEC on 2019-09-19. The offering totals $2.2M, of which $2.2M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2019-09-19
- Form: D/A
- Accession: 0001786525-19-000002
- Industry: Pooled Investment Fund
- Exemptions: 06c, 3C, 3C.1
- Total offering: $2.2M
- Amount sold: $2.2M
- Minimum investment: $10K
- Investors: 27
- Date of first sale: 2019-06-07
- Security types: fund interests
- SEC file number: 021-341608
Issuer
- Name: Revelis BioEclipse SPV LLC, a Series of Revelis SPV Master, LLC
- CIK: 0001748549
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2420 17th St, Denver, CO, 80202
- Phone: 2034512020
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| LLC Revelis Capital Group | Director | Denver, CO |
| LLC Assure Fund Management II | Executive Officer | Salt Lake City, UT |
| Jeremy Neilson | Executive Officer | Salt Lake City, UT |
| Richard Thoms | Executive Officer | Salt Lake City, UT |
| LLC Assure Fund Management II | Director | Salt Lake City, UT |
Other filings by this issuer (1)
More